>Brookings Oregon News, Sports, & Weather | The Curry Coastal Pilot

News Classifieds Web
web powered by Web Search Powered by Google

News arrow News arrow Business arrow POTTERY SHOP NAMED FOR STRAY PUP

POTTERY SHOP NAMED FOR STRAY PUP Print E-mail
June 23, 2000 11:00 pm

People may find many things are big and heavy at Najas Pottery shop in Harbor, including the mascot, a 250-pound dog named Naja.

No one should be scared though as Naja appears to be friendly, just like his masters and shop owners Mike and Joan Hebert, who named the business after him.

The Heberts came to Brookings from Minneapolis. It was there that they found an abandoned pup in the garbage. They adopted the dog, who was named by their daughter, who provided part of her bed for Naja to sleep.

About the same time the Heberts adopted Naja, Mike was in an accident in the truck he drove cross-country. He decided to retire.

Because Joan grew up in Roseburg, they came to Oregon on vacations, including the coast. They chose to move here.

We have everything here, Mike Hebert said of the mountains, oceans and rivers.

After three years of planning to open a pottery shop, their plans became a reality.

The shop, located at 15633 Highway 101 next to Great American Smokehouse, offers all handmade pottery, Hebert said. The stock includes everything from big items to small including religious statues, handmade dishes, cups, fireplaces and more.

Not everything is pottery. There also is a small line of wooden windmills made by a woodworker in Hiouchi, Hebert said.

His pottery inventory comes from eight potters from Grants Pass to Mount St. Helens, Hebert said.

Najas Pottery is open everyday except Wednesdays from 10 a.m. to 7 p.m. For information, call (541) 412-7056.

 

Business News by Yahoo Finance

  • GM to battle VW in China with $12 billion investment and new plants
    U.S. car giant General Motors Corp (GM) (GM) plans to invest $12 billion in China from 2014 to 2017 and build more plants next year as it competes with aggressive rivals in the world's largest auto market. GM expects its China sales to expand 8-10 percent this year, in line with the overall growth of the Chinese market, where foreign firms, such as Volkswagen AG (VOW3.DE), and domestic players like SAIC Motor Corp vie for more market share. In total we are investing $12 billion between 2014 and 2017," Matt Tsien, president of GM China, said at the Auto China show in Beijing. GM plans to build five more plants in China next year, as part of its efforts to ramp up manufacturing capacity there by 65 percent by 2020, executives said on Sunday.
  • Pipeline delay gives boost to Obama's political base
    The latest delay to a final decision on the Keystone XL oil pipeline will reinforce a White House strategy to energize President Barack Obama's liberal-leaning base before fall elections in which Democrats risk losing control of the U.S. Senate. Environmentalists, worried about the project's effect on climate change, have put enormous pressure on the president to reject the pipeline from Canada's oil sands, staging demonstrations outside the White House and protests in states where he travels. A decision to approve it now could have prompted that vocal group, which was instrumental in electing Obama in 2008 and 2012, to sit out the November 4 congressional elections. The State Department's announcement on Friday that it would give government agencies more time to study the project was seen by strategists from both parties as a move to prevent that and boost Obama in the eyes of his supporters.
  • Pfizer considers $100 billion bid for AstraZeneca: report
    U.S. pharmaceutical giant Pfizer (PFE) has approached British rival AstraZeneca (AZN.L) to propose a 60 billion pound ($101 billion) takeover, Britain's Sunday Times reported. The paper cited senior investment bankers and industry sources saying that informal conversations about a deal had taken place between the two but that no talks were currently under way after AstraZeneca resisted the approach. Pfizer and AstraZeneca both declined to comment on the report to Reuters. AstraZeneca, Britain's second-biggest pharmaceuticals group, has been frequently touted as a potential takeover target as it wrestles with patents expiring on a number of best-selling drugs, leaving future growth uncertain.

Follow Curry Coastal Pilot headlines on Follow Curry Coastal Pilot headlines on Twitter

© Copyright 2001 - 2014 Western Communications, Inc. All rights reserved. By Using this site you agree to our Terms of Use